Lung Cancer Clinical Trial
Official title:
Meaning of Recovery to Patients Undergoing Lung Cancer Surgery: A Prospective Observational Study
The purpose of this study is to find out the meaning of recovery after lung cancer surgery from a patient's point of view. The results of this study would help improve postoperative recovery in lung cancer patients.
Status | Recruiting |
Enrollment | 111 |
Est. completion date | August 10, 2024 |
Est. primary completion date | July 10, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Patients aged 19 to 80 years undergoing video-assisted thoracic surgery (VATS) lung resection for lung cancer - Patients who can provide written consent to participate in clinical trials, understand the procedures of this clinical trial, and properly fill out patient-reported questionnaires or respond appropriately to interviews Exclusion Criteria: - Patients who did not consent to the trial - Patients who have difficulty filling out questionnaires or answering interviews about the meaning of recovery - Patients judged to be inappropriate for this clinical trial based on the opinion of the investigator or investigator |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Importance score of each question regarding the meaning of recovery after lung cancer surgery before surgery | Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient. | 1 day before surgery | |
Primary | Importance score of each question regarding the meaning of recovery after lung cancer surgery at postoperative day 2 | Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient. | postoperative day 2 | |
Primary | Importance score of each question regarding the meaning of recovery after lung cancer surgery at postoperative day 30 | Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient. | postoperative day 30 (between day 25 and 35) | |
Secondary | Recovery score (0~100 scale) | Patient self-assessed recovery score (0-100 scale, higher number means better recovery) | postoperative day 2, and postoperative day 30 (between day 25 and 35) | |
Secondary | Recovery score evaluated with 15-item Quality of Recovery (QoR-15K) scale | Recovery score evaluated with QoR-15K scale (0-150 scale, higher number means better recovery) | postoperative day 2 | |
Secondary | Length of hospital stay (day) | Days from the end of surgery to discharge | Hospital discharge, an average of 3 days | |
Secondary | Length of ICU stay (day) | Days from the end of surgery to ICU discharge | ICU discharge, an average of 1 day | |
Secondary | Postoperative complication | Postoperative complication related to surgery until postoperative day 30 | Postoperative day 30 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|